Literature DB >> 2508750

Changes in mRNA levels of poly(ADP-ribose) polymerase during activation of human lymphocytes.

R McNerney1, M Tavasolli, S Shall, A Brazinski, A Johnstone.   

Abstract

The level of mRNA encoding the nuclear enzyme poly(ADP-ribose) polymerase (ADP-ribosyltransferase, EC 2.4.2.30) was found to be very low in quiescent human lymphocytes and to increase at least 10-fold between 1 and 2 dyas after stimulation with the mitogen phytohaemagglutinin, staying high for several days thereafter. This increase was inhibited by 3-methoxybenzamide (a competitive inhibitor of poly(ADP-ribose) polymerase) but was not affected significantly by aphidicolin. Incubation of activated cells with cycloheximide for 2 h increased the expression slightly. These data demonstrate that, during lymphocyte activation, the level of mRNA of the poly(ADP-ribose) polymerase gene correlates with, and hence is presumably responsible for, the increase in poly(ADP-ribose) polymerase protein detectable by enzyme assay or immunochemistry.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2508750     DOI: 10.1016/0167-4781(89)90099-7

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  8 in total

1.  Inhibitors of poly(ADP-ribose) polymerase-1 suppress transcriptional activation in lymphocytes and ameliorate autoimmune encephalomyelitis in rats.

Authors:  Alberto Chiarugi
Journal:  Br J Pharmacol       Date:  2002-11       Impact factor: 8.739

2.  Long-term suppression of EAE relapses by pharmacological impairment of epitope spreading.

Authors:  L Cavone; B Peruzzi; R Caporale; A Chiarugi
Journal:  Br J Pharmacol       Date:  2014-03       Impact factor: 8.739

Review 3.  Molecular and biochemical features of poly (ADP-ribose) metabolism.

Authors:  D Lautier; J Lagueux; J Thibodeau; L Ménard; G G Poirier
Journal:  Mol Cell Biochem       Date:  1993-05-26       Impact factor: 3.396

4.  Regulation by phosphorylation of Xenopus laevis poly(ADP-ribose) polymerase enzyme activity during oocyte maturation.

Authors:  S Aoufouchi; S Shall
Journal:  Biochem J       Date:  1997-07-15       Impact factor: 3.857

5.  Purification and characterization of NAD+:ADP-ribosyltransferase (polymerizing) from Dictyostelium discoideum.

Authors:  B Kofler; E Wallraff; H Herzog; R Schneider; B Auer; M Schweiger
Journal:  Biochem J       Date:  1993-07-01       Impact factor: 3.857

6.  Poly(ADP-ribose) catabolism in mammalian cells.

Authors:  J Lagueux; G M Shah; L Ménard; H Thomassin; C Duchaine; C Hengartner; G G Poirier
Journal:  Mol Cell Biochem       Date:  1994-09       Impact factor: 3.396

7.  Characterization of rat lymphocyte primary culture for the development of an in-vitro mutagenesis assay: effect of interleukin-2 and 2-mercaptoethanol on the activities of intermediary metabolism enzymes and cell proliferation.

Authors:  A Aidoo; R J Feuers; L E Lyn-Cook; M E Bishop; D A Casciano
Journal:  Cell Biol Toxicol       Date:  1996-04       Impact factor: 6.691

8.  Catastrophic NAD+ depletion in activated T lymphocytes through Nampt inhibition reduces demyelination and disability in EAE.

Authors:  Santina Bruzzone; Floriana Fruscione; Sara Morando; Tiziana Ferrando; Alessandro Poggi; Anna Garuti; Agustina D'Urso; Martina Selmo; Federica Benvenuto; Michele Cea; Gabriele Zoppoli; Eva Moran; Debora Soncini; Alberto Ballestrero; Bernard Sordat; Franco Patrone; Raul Mostoslavsky; Antonio Uccelli; Alessio Nencioni
Journal:  PLoS One       Date:  2009-11-19       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.